Bicara Therapeutics Inc.

Nasdaq:BCAX

Pharmaceutical Preparations·BOSTON, MA

CEO

Mazumdar Claire

CFO

Hyep Ivan

Financials

5 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→

Earnings Releases (8-K)

6 shown

Filed	Period
2/26/26	Q1 FY2026	→
11/10/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/27/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→

News (8-K)

7 shown

Filed	Type	Description
2/19/26	Other	Other Events	→
1/12/26	Other	Other Events	→
12/8/25	Reg FD	Regulation FD Disclosure	→
6/12/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/6/25	Agreement	Entry into a Material Definitive Agreement	→
1/13/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

14 shown

Filed	Form	Description
2/26/26	424B5	424B5	→
2/25/26	FWP	FWP	→
2/24/26	424B5	424B5	→
11/26/25	424B5	424B5	→
10/3/25	S-3	S-3	→
4/25/25	ARS	ARS	→
↓

Filing History(177 filings)

TypeDateAccessionPeriodSize

144

Mar 9, 2026

0001969223-26-000319

—

6.0 KB

Mar 6, 2026

0001628280-26-015778FORM 4

Mar 4, 2026

19.2 KB

144

Mar 6, 2026

0001969223-26-000309

—

5.4 KB

Mar 5, 2026

0001628280-26-015423FORM 4

Mar 3, 2026

10.1 KB

Mar 5, 2026

0001628280-26-015421FORM 4

Mar 3, 2026

17.5 KB

Mar 5, 2026

0001628280-26-015419FORM 4

Mar 3, 2026

13.4 KB

144

Mar 5, 2026

0001969223-26-000297

—

4.8 KB

144

Mar 4, 2026

0001969223-26-000283

—

6.0 KB

144

Mar 4, 2026

0001969223-26-000282

—

4.3 KB

144

Mar 4, 2026

0001969223-26-000280

—

4.8 KB

144

Mar 3, 2026

0001969223-26-000275

—

5.4 KB

144

Mar 3, 2026

0001969223-26-000274

—

4.3 KB

144

Mar 3, 2026

0001969223-26-000272

—

7.2 KB

SCHEDULE 13D/A

Mar 2, 2026

0001346824-26-000066

—

16.1 KB

Mar 2, 2026

0001231919-26-000231

Feb 26, 2026

15.6 KB

Feb 27, 2026

0001628280-26-012823FORM 4

Feb 25, 2026

10.1 KB

8-K

Feb 26, 2026

0001193125-26-0765608-K

Feb 24, 2026

479.0 KB

424B5

Feb 26, 2026

0001193125-26-072875424B5

—

869.9 KB

144

Feb 25, 2026

0001969223-26-000230

—

6.6 KB

FWP

Feb 25, 2026

0001193125-26-068187FWP

—

68.1 KB

424B5

Feb 24, 2026

0001193125-26-067160424B5

—

845.0 KB

8-K

Feb 19, 2026

0001628280-26-0098088-K

Feb 19, 2026

308.6 KB

SCHEDULE 13G/A

Feb 17, 2026

0000902664-26-001089

—

10.5 KB

SCHEDULE 13G

Feb 17, 2026

0001897612-26-000288

—

7.2 KB

SCHEDULE 13G

Feb 12, 2026

0001172661-26-000689

—

10.9 KB

25 filings shown

Bicara Therapeutics Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(177 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/6/26	4	4	→
3/5/26	4	4	→
3/5/26	4	4	→
3/5/26	4	4	→
3/2/26	4	4	→
2/27/26	4	4	→
↓

Filed	Form	Description
3/9/26	144	144	→
3/6/26	144	144	→
3/5/26	144	144	→
3/4/26	144	144	→
3/4/26	144	144	→
3/4/26	144	144	→
↓